v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2023   235,777        
Beginning balance at Jan. 31, 2023 $ 1,487,434 $ 118 $ 2,612,705 $ (1,148,163) $ (1,019) $ 23,793
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   846        
Issuance of common stock upon exercise of options 6,176 $ 1 6,175      
Issuance of common stock under RSU and PSU release (in shares)   2,899        
Issuance of common stock under employee stock purchase plan (in shares)   450        
Issuance of common stock under employee stock purchase plan 45,432 $ 1 45,431      
Issuance of common stock for restricted stock awards (in shares)   125        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   23        
Issuance of common stock for founders holdbacks related to acquisitions 3,426   3,426      
Issuance of common stock for payment of board of director fees (in shares)   2        
Issuance of common stock for payment of board of director fees 255   255      
Stock-based compensation expense, net of founder revest 451,590   451,590      
Capitalized stock-based compensation 26,411   26,411      
Fair value of replacement equity awards attributable to pre-acquisition service 652   652      
Net income (loss) 35,644     35,628   16
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) (4,261)       (4,261)  
Ending balance (in shares) at Oct. 31, 2023   240,122        
Ending balance at Oct. 31, 2023 2,060,847 $ 120 3,146,645 (1,112,535) (5,280) 31,897
Beginning balance (in shares) at Jul. 31, 2023   238,775        
Beginning balance at Jul. 31, 2023 1,870,100 $ 119 2,976,375 (1,139,200) 913 31,893
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   261        
Issuance of common stock upon exercise of options 2,051 $ 1 2,050      
Issuance of common stock under RSU and PSU release (in shares)   955        
Issuance of common stock for restricted stock awards (in shares)   125        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   5        
Issuance of common stock for founders holdbacks related to acquisitions 888   888      
Issuance of common stock for payment of board of director fees (in shares)   1        
Issuance of common stock for payment of board of director fees 88   88      
Stock-based compensation expense, net of founder revest 158,649   158,649      
Capitalized stock-based compensation 7,943   7,943      
Fair value of replacement equity awards attributable to pre-acquisition service 652   652      
Net income (loss) 26,669     26,665   4
Other comprehensive income (loss) (6,193)       (6,193)  
Ending balance (in shares) at Oct. 31, 2023   240,122        
Ending balance at Oct. 31, 2023 2,060,847 $ 120 3,146,645 (1,112,535) (5,280) 31,897
Beginning balance (in shares) at Jan. 31, 2024   241,865        
Beginning balance at Jan. 31, 2024 $ 2,337,089 $ 121 3,364,328 (1,058,836) (1,663) 33,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 416 416        
Issuance of common stock upon exercise of options $ 3,308   3,308      
Issuance of common stock under RSU and PSU release (in shares)   3,502        
Issuance of common stock under RSU and PSU release 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099   56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   8        
Issuance of common stock for founders holdbacks related to acquisitions 2,667   2,667      
Issuance of common stock for payment of board of director fees 261   261      
Stock-based compensation expense, net of founder revest 586,598   586,598      
Capitalized stock-based compensation 31,934   31,934      
Fair value of replacement equity awards attributable to pre-acquisition service 468   468      
Net income (loss) 76,135     73,011   3,124
Non-controlling interest 1,415         1,415
Other comprehensive income (loss) (363)       (363)  
Ending balance (in shares) at Oct. 31, 2024   246,309        
Ending balance at Oct. 31, 2024 3,095,611 $ 124 4,045,660 (985,825) (2,026) 37,678
Beginning balance (in shares) at Jul. 31, 2024   245,122        
Beginning balance at Jul. 31, 2024 2,890,590 $ 123 3,824,897 (969,003) (3,102) 37,675
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   116        
Issuance of common stock upon exercise of options 844   844      
Issuance of common stock under RSU and PSU release (in shares)   1,068        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   3        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for payment of board of director fees 86   86      
Stock-based compensation expense, net of founder revest 206,489   206,489      
Capitalized stock-based compensation 12,456   12,456      
Net income (loss) (16,819)     (16,822)   3
Other comprehensive income (loss) 1,076       1,076  
Ending balance (in shares) at Oct. 31, 2024   246,309        
Ending balance at Oct. 31, 2024 $ 3,095,611 $ 124 $ 4,045,660 $ (985,825) $ (2,026) $ 37,678